Holen Sie sich die Stockscreener-App
44.75
6.45%
2.71
Handel nachbörslich:
43.00
-1.75
-3.91%
Qiagen Nv Aktie (QGEN) Neueste Nachrichten
Qiagen stock after-hours at EUR 38.04: minus 1.73 percent versus prior close - AD HOC NEWS
Global Liver Cancer Diagnostics Market to Observe Impressive Growth at a CAGR of ~9% by 2034 | DelveInsight - GlobeNewswire Inc.
Qiagen launches QIAmini as Qiagen stock sits 17.73 percent below its high - AD HOC NEWS
Qiagen stock last at EUR 38.72 on September 30, 2026 - AD HOC NEWS
Qiagen stock last at EUR 38.72 on September 30, 2026, down 1.02 percent - AD HOC NEWS
Release according to Article 40, Section 1 of the WpHG - TradingView
QIAGEN N.V. (QIA): BlackRock Holds 12.97% Voting Rights - TradingView
QIAGEN N.V. (QIA) Reports AFM BlackRock Voting Rights Notice - TradingView
QIAGEN N.V. (QIA) Discloses AFM Notice on BlackRock Voting Rights - TradingView
QIAGEN N.V. (QIA) Reports AFM Voting Rights Notice - TradingView
Qiagen N.V. (QGEN) Stock Price, News, Quote & History - Yahoo! Finance Canada
QIAGEN Completes U.S. QIAstat-Dx Bloodstream Infection Portfolio With FDA Clearance of New Bacteria Detection Panel - BioBuzz
Qiagen stock expands its sepsis testing portfolio - AD HOC NEWS
Qiagen stock last at EUR 39.12 on September 29, 2026: minus 0.46 percent versus Xetra close - AD HOC NEWS
Qiagen NV (CEUX:QIAD) Cyclically Adjusted PB Ratio : (As of Sep. 29, 2026) - GuruFocus
Qiagen NV at Citi Global Healthcare Conference Transcript - GuruFocus
Qiagen stock last stood at EUR 39.08 as FDA tests expand - AD HOC NEWS
Preliminary Q1 2026 Qiagen NV Earnings Call Transcript - GuruFocus
Qiagen (QGEN), What Is Behind The Fresh Attention Now? - Yahoo Finance
Qiagen grounds drug discovery agents in curated knowledge - SiliconANGLE
Qiagen stock at USD 45.47 on September 28, 2026 - AD HOC NEWS
Veterinary Diagnostics Market Size to Soar to USD 30.78 Billion by 2035 at a CAGR of 10.1% - GlobeNewswire Inc.
Qiagen stock gets a fresh FDA catalyst from QIAstat-Dx - AD HOC NEWS
QIAGEN says FDA cleared second QIAstat‑Dx bloodstream panel - Mugglehead Investment Magazine
A new infection test finds 13 bacteria and 18 signs of antibiotic resistance in about an hour. - Stock Titan
Qiagen N.V. (NYSE:QGEN) Stock Has Consensus Target Price of $43.51 - MarketBeat
Qiagen stock last at EUR 39.470, up 1.64 percent in Xetra trading - AD HOC NEWS
Warren Wise decodes Qiagen’s DNA - TradingView
Qiagen stock gains 1.94 percent with Q2 results above estimates - AD HOC NEWS
Qiagen launches QIAmini to automate small-batch sample preparation - BioSpectrum Asia
Qiagen N.V. $QGEN Holdings Raised by State Street Corp - MarketBeat
Qiagen stock gains 1.43 percent ahead of the open - AD HOC NEWS
Qiagen launches compact automated sample prep system - Investing.com
Qiagen launches compact automated sample prep system By Investing.com - Investing.com Nigeria
QIAGEN Launches QIAmini to Automate Small-Batch Sample Preparation - marketscreener.com
Qiagen launches compact QIAmini sample prep system for small labs - StreetInsider
Here's Why You Should Hold QIAGEN Stock in Your Portfolio for Now - Yahoo Finance
Qiagen N.V. : Deutsche Bank remains its Buy rating - marketscreener.com
QIAGEN (NYSE:QGEN) Eyes Breakout With Technical Rating 7 and Setup Rating 9 - ChartMill
Qiagen stock heads into the open after a 3.4 percent gain - AD HOC NEWS
Qiagen stock was last quoted at USD 44.78 after the close - AD HOC NEWS
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
QIAGEN N.V. (QIA) Receives AFM Notice on BlackRock Voting Rights - TradingView
QIAGEN N.V. (QIA) Notified of Millennium 2.99% Stake - TradingView
QIAGEN N.V. (QIA) AFM Posts Voting Rights Notice - TradingView
QIAGEN N.V. (QIA) Discloses Goldman Sachs 3.41% Voting Rights - TradingView
QIAGEN N.V. (QIA) Notes AFM Voting Rights Filing by Goldman Sachs - TradingView
QIAGEN N.V. (QIA) Notes AFM Voting Rights Notification - TradingView
QIAGEN N.V. (QIA) Reports AFM Notice of BlackRock Voting Rights - TradingView
QIAGEN N.V. (QIA) Notes AFM Filing on BlackRock Voting Rights - TradingView
Qiagen stock holds at USD 44.78 below its yearly high - AD HOC NEWS
Qiagen stock heads into the open after a 1.36 percent drop - ad-hoc-news.de
Qiagen stock was last quoted after the close - AD HOC NEWS
Qiagen stock gains 3.05 percent near its yearly range - AD HOC NEWS
Qiagen stock heads into the open after a flat close - AD HOC NEWS
A Look at Qiagen NV (QGEN) After 3.4% Gain -- GF Value $49.88 vs Price $44.78 - gurufocus.com
Qiagen stock ends the day unchanged at the close on the NYSE - AD HOC NEWS
Qiagen stock reacts to CEO change and modest analyst upside - AD HOC NEWS
QIAGEN Calls Extraordinary General Meeting for Appointment of Jonathan M. Pratt to Managing Board - marketscreener.com
Qiagen N.V. (QGEN) Stock Forecasts - Yahoo Finance
Qiagen N.V. (QGEN) Stock Report: A Healthcare Giant With A Potential Upside Of 6.78% - DirectorsTalk Interviews
Qiagen N.V. (QGEN) Presents at Berenberg and Goldman Sachs 15th German Corporate Conference 2026Slideshow (NYSE:QGEN) 2026-09-21 - Seeking Alpha
Qiagen stock heads into the open after a 2.27% drop - AD HOC NEWS
Qiagen stock slips after earnings beat narrows upside - AD HOC NEWS
Qiagen stock gains institutional backing as BlackRock stake disclosed - AD HOC NEWS
Qiagen schedules shareholder vote on new CEO appointment By Investing.com - Investing.com Canada
0.97%
0.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):